Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases

SIMPLE SUMMARY: Novel therapeutic targets are needed to improve treatments of aggressive cancers and viral diseases. Tetraspanins represent an emerging class of anticancer targets, notably the transmembrane protein CD81 which has been structurally well characterized. CD81 plays key roles in tumor gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bailly, Christian, Thuru, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093296/
https://www.ncbi.nlm.nih.gov/pubmed/37046846
http://dx.doi.org/10.3390/cancers15072186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093296/
https://www.ncbi.nlm.nih.gov/pubmed/37046846
http://dx.doi.org/10.3390/cancers15072186

Ejemplares similares